| Poster Programme |
| P 1 |
Chip based point-of-care analysis for the detection of epizootics - autonomous epizootic lab-on-a-chip system
B. Seise, R. Kretschmer, University of Jena/D; M. Urban, T. Henkel, Institute of Photonic Technology e.V., Jena/D; J. Popp, R. Moeller, University of Jena/D |
| P 3 |
Selecting the right decontaminating agent
M. Czarneski, Clordisys Solutions Inc., Lebanon, NY/USA |
| P 4 |
Integration of biorisk management into a facility-wide safety structure - combining the CWA15793 standard with existing management norms and standards
D. Kümin, M. Strasser, M. Schütz, S. Breitenbaumer, M. Zanni, Federal Office of Civil Protection, Spiez/CH |
| P 6 |
A safety assured approach to building contained rooms
G. Farquharson, Critical Systems Ltd., Guildford/UK |
| P 7 |
Improving national biological risk assessment methodology and encouraging international coordination of biological risk assessment, management and mitigation
T. Trevan, International Council for the Life Sciences, Washington DC/USA |
| P 8 |
Unauthorized genetically modified organisms
M. Milavec, J. Zel, National Institute of Biology, Ljubljana/SLO |
| P 9 |
Enhancing biosafety and biosecurity in the Middle East and North Africa
K. Riffi Temsamani, Université Abdelmalek Essaâdi, Tétouan/MA |
| P 11 |
Testing of disinfectant concentration in solution with B. stearothermophilus biological indicators
U. Pauli, K. Summermatter, Institute of Virology and Immunoprophylaxis, Mittelhäusern/CH |
| P 12 |
Management model for a multiple purpose BSL3/ABSL3 laboratory in Argentina
S.D.L. Miguel, L. Vizzotti, S. Gonzalez Capria, M.M. Bassani Molinas, A.E. Vilardo, L. Vazquez, A. Edelstein, Administracion Nacional De Laboratorios E Institutos De Saludargentina, Buenos Aires/RA |
| P 13 |
Italian biosafety plattform
ITALIAN BIOSAFETY PLATFORM, IBP, Siena/I |
| P 14 |
Novel heat-sterilisation type air-cleaning system
N. Fujita, T. Komori, Kyoto Prefectural University of Medicine, Kyoto/J; S. Ohara, Oparz Co.Ltd, Kyoto/J |
| P 15 |
From the DNA sequences to the biological risk estimation: a molecular study on the airborne Aspergillus and Penicillium taxa at workplaces
D. Davolos, Environment Dept (DIPIA), National Institute of Occupational Safety and Prevention (ISPESL), Rome/I; L. Nelli, Siena Biotech S.p.A., Siena/I; B. Pietrangeli, Environment Dept (DIPIA), National Institute of Occupational Safety and Prevention (ISPESL), Rome/I |
| P 16 |
The international federation of biosafety associations
J. Reed, International Centre for Infectious Diseases, Frederick/USA |
| P 17 |
Lack of transparency on environmental risks assessment of genetically engineered crops before their commercial release
B. Sorochinsky, Institute of Food Biotechnology and Genomics, Kiev/UA |
| P 18 |
Design and delivery of a basic biosafety training programme in Azerbaijan
J. Shallcross, Health Protection Agency, Salisbury/UK; M. Reynolds, dstl, Salisbury/UK; N. Silman, D. Nash, Health Protection Agency, Salisbury/UK; T. Guthrie, Raytheon, Baku/AZ; D. Elliot, UK MoD, Salisbury/UK |
| P 19 |
Web-based biorisk management education for co-medical laboratory worker course students
M. Shigematsu, National Institute of Infectious Diseases, Tokyo/J; S. Fujimoto, Kyushu University, Fukuoka/J |
| P 20 |
Identification and quantification of pathogens through an analysis of DNA markers using high throughput mass spectrometry
H. Gueltekin, R. O. Bulte, Abbott GmbH & Co. KG, Wiesbaden/D |
| P 21 |
The significance of the BSO in the realization and design of an ABSL2/3 facility
B. Joosten, C. Haasnoot, A. van Velden, P. Odinot, University of Utrecht/NL |
| P 22 |
How GPS works when your pathogens is transported
K. Shinohara, National Institute of Infectious Diseases Japan, Musashimurayama Tokyo/J; T. Kurata, Toyama Institute of Health, Imizu Toyama/J; A. Takada, Hokkaido University Reseach Center for Zoonosis Control, Sapporo Hokkaido/J; R. Komatsu, Yamato System Development Co., Ltd., Tokyo/J |
| P 23 |
Case study of airflow and pressurization control in BSL-3 facility
K. Shinohara, National Institute of Infectious Diseases Japan, Musashimurayama Tokyo/J; T. Fukui, Ministry of Land Infrastructure and Transport, Tokyo/J; K. Fukumoto, Nikken Sekkei Ltd., Tokyo/J; K. Obara, Kawasaki Setsubi Kogyo Co., Ltd., Tokyo/J; M. Ishihara, Yamatake Corporation, Tokyo/J |
| P 24 |
Quarantine containment of plant pathogens: regulation and implementation in England and Wales
J. Morris, S. Bishop, Food and Environment Research Agency, York/UK |
| P 25 |
Biosafety and biosecurity good practices in france: implementation of a new guidance
C. Genisset, M. Eymery, C. Stern, M. Pampin, M. Lheritier-Barrand, D. Masset, P.H. Bertoye, M. Stoltz, Afssaps, Saint-Denis/F |
| P 26 |
Development of validation protocols for a new BSL3/ABSL3 containment laboratory
B. Fontes, Yale University, New Haven, CT/USA |
| P 27 |
Biosecurity education as the way to enhance biotechnology safety
O. Kysil, National Taras Shevchenko University of Kyiv/UA; S. Komisarenko, Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Kyiv/UA |
| P 28 |
Safety cabinets: the influence of dynamic interference factors on the safety function
T. Hinrichs, Berner International GmbH, Elmshorn/D |
| P 29 |
Case study: versatile construction methodology meeting high demands for air-tightness (BSL 2-3-4)
C. Rasmussen, ALECTIA A/S, Virum/DK; O. Holst, Langvad A/S, Hørsholm/DK; C. Bjørlund, JAKON A/S, Ballerup/DK |
| P 30 |
Lentiviral Vectors - how to control the biosafety issues
D. Seger, The Weizmann Institute of Science, Rehovot/IL |
| P 31 |
Defining the role of ECDC in biosafety: establishment of a Biorisk Expert Group
A. Bennett, Health Protection Agency, Porton Down/UK; G. Burns, Astra Zeneca, Macclesfield/UK; A. Davies, Health Protection Agency, Porton Down/UK; I. Kallings, Consultant, Stockholm/S; E. Kampert, RIVM, Bilthoven/NL; S. McAdam, DNV, Oslo/N; J. Mertsching, Hannover Medical School, Hannover/D; H. Sheeley, Health Protection Agency, Porton Down/UK; K. Summermatter, IVI, Mittelhausen/CH; A. Szekely Bjorndal, SMI, Stockholm/S; A. Ozin, ECDC, Stockholm/S |
| P 32 |
The assessing of the biorisks at laboratory manipulations with the exciters of especially dangerous infections as an element of the biosafety trainings
V. Pushkina, V. Samoylenko, Ukrainian Anti-Plague Research Institute after I.I. Mechnikov, Odessa/UA |
| P 33 |
Implementation of the Laboratory Biorisk Management Standard CWA 15793:2008 in the BSL3-Laboratory of the Bavarian Health and Food Safety Authority
C. Aurnhammer, U. Busch, S. Hörmansdorfer, Bavarian Health and Food Safety Authority, Oberschleißheim/D |
| P 34 |
BBP; a model for regional working groups of EBSA
R. Custers, VIB, Zwjinaarde/B; T. De Kesel, Bayer BioScience, Gent/B; S. Loret, University of Namur/B; M. Schoukens, K.U.Leuven/B; P. Stroot, Xibios, Tournai/B |
|
